In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4

Antiviral strategies against influenza virus: towards new therapeutic approaches

(2014) Arianna Loregian et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

(2014) Jenny G Low et al.   LANCET INFECTIOUS DISEASES

Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections

(2014) Mohammed A. Sadat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emerging Principles for the Therapeutic Exploitation of Glycosylation

(2014) Martin Dalziel et al.   SCIENCE

Pandemic potential of avian influenza A (H7N9) viruses

(2014) Tokiko Watanabe et al.   TRENDS IN MICROBIOLOGY

The epidemiology and spread of drug resistant human influenza viruses

(2014) Aeron C Hurt   Current Opinion in Virology

An iminosugar with potent inhibition of dengue virus infection in vivo

(2013) Stuart T. Perry et al.   ANTIVIRAL RESEARCH

Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions

(2013) Jinhong Chang et al.   ANTIVIRAL RESEARCH

Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial

(2012) Satoru Watanabe et al.   ANTIVIRAL RESEARCH

Gastrointestinal disturbances and their management in miglustat-treated patients

(2011) Nadia Belmatoug et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins

(2010) Steven J. Gamblin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY